Kerala Drugs and Pharmaceuticals looks to vaccine manufacturers for supply of APIs
May 05, 2021
Vaccine production from company’s manufacturing facility can help address the shortage issue
The State-owned Kerala State Drugs & Pharmaceuticals (KSDP) has approached Covid vaccine manufacturers for getting vaccines in concentrated form in order to fill it in vials.
The company s new non beta-lactam injection plant facility in Alappuzha can be utilised for filling Covid vaccines in vials by making some modifications in the machinery. “We have already contacted Bharat Biotech and the other vaccine manufacturing company in this regard,” highly placed sources told
BusinessLine.
The production of Covid vaccine from KSDP’s manufacturing facility could help address the shortage currently being faced in the State and distribute it evenly to other parts in South India without any hindrances. However, the sources went on to add that it all depends on the availability of concentrat
Funds for upgrade of schools, universities, hospitals
As many as 77 projects estimated to cost ₹2,613.38 crore has been given the nod by the executive and governing body of the Kerala Infrastructure Investment Fund Board (KIIFB) that met here on Monday.
With the approvals, the KIIFB funds provided to infrastructure and development projects has risen to ₹63,250.66 crore. Of these, ₹43,250.66 crore is for 889 infrastructure projects and ₹20,000 crore for six land acquisition projects.
The KIIFB executive and governing body has given the nod on Monday for the upgrade of 147 schools at a cost of ₹433.46 crore and ₹175.12 crore for the infrastructure development of the Universities of Kerala, Kozhikode and Kannur and revamp of the College of Arts and Science, Thazava.